Cargando...
Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery
BACKGROUND: Warfarin is an anticoagulant and is widely used for the prevention of thromboembolic events. Genetic variants of the enzymes that metabolize warfarin, i.e. cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various w...
Guardado en:
| Publicado en: | Res Cardiovasc Med |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Kowsar
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592525/ https://ncbi.nlm.nih.gov/pubmed/26448196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.27963v2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|